EDGAR Filing Documents for 0001811764-21-000028

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001811764-21-000028

Filing Date

2021-12-01

Accepted

2021-12-01 08:25:49

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	pnt-424b3forform8xkexecuti.htm	424B3	6084
2	EX-99	pnt-form8xkexecutiveoffice.htm	EX-99	31389
3	EX-99.1	a20211201-pointannounces.htm	EX-99.1	10009
4	GRAPHIC	a20211201-pointannounces001.jpg	GRAPHIC	243471
5	GRAPHIC	a20211201-pointannounces002.jpg	GRAPHIC	272497
6	GRAPHIC	a20211201-pointannounces003.jpg	GRAPHIC	237156
7	GRAPHIC	image_0.jpg	GRAPHIC	7287
	Complete submission text file	0001811764-21-000028.txt		1096294

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 211461503
SIC: 2834 Pharmaceutical Preparations